Alyx Arnett

4 weeks ago | sleepreviewmag.com | Alyx Arnett

Wearable sleep rings are gaining ground, thanks to their comfort, simplicity, and growing clinical utility. US Food and Drug Administration (FDA)-cleared rings are being used not only for diagnostic sleep testing but also for longitudinal monitoring, while consumer rings drive more attention to sleep health. Companies like SleepImage and Belun Technology market rings cleared for diagnosing obstructive sleep apnea and evaluating sleep stages.

1 month ago | sleepreviewmag.com | Alyx Arnett

Treating sleep apnea with a neurostimulator, such as Inspire for obstructive sleep apnea (OSA) or remedē for central sleep apnea (CSA), requires much more than one clinic visit. Steps include identifying a candidate, scheduling and undergoing implantation, activating the device, and titrating it—all before finally having the potential for optimal nightly use. Delays can occur at any stage, prolonging the process and leaving patients untreated.

1 month ago | sleepreviewmag.com | Alyx Arnett

Sleep specialists can increase their role in the early detection of cardiac comorbidities in sleep apnea patients. Sleep Review’s Cardiology-Sleep Solutions column shares new technologies that can help. Email [email protected] with solutions you’d like to see featured here. Electrocardiogram (ECG) is a standard channel during in-lab polysomnography (PSG) but is generally absent from home sleep testing (HST) devices.

Dec 13, 2024 | sleepreviewmag.com | Alyx Arnett

Summary: The European Medicines Agency (EMA) has determined that Eli Lilly’s Mounjaro (tirzepatide), approved for weight management, does not require a separate indication for treating obstructive sleep apnea (OSA) in adults with obesity. Clinical data from two studies showed Mounjaro improves OSA symptoms by reducing weight. However, the EMA concluded these benefits are already covered under its existing approval for obesity treatment.

Nov 20, 2024 | sleepreviewmag.com | Alyx Arnett

Dopamine agonists make up three of the four US Food and Drug Administration (FDA) approved medications for restless legs syndrome (RLS), and they are the most commonly prescribed drugs for RLS.1 The American Academy of Sleep Medicine (AASM) now recommends against them.